ArticleCardiovascular diabetology2023

The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice.

Yue Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.